Cargando…
Transferrin-Conjugated SNALPs Encapsulating 2′-O-Methylated miR-34a for the Treatment of Multiple Myeloma
Stable nucleic acid lipid vesicles (SNALPs) encapsulating miR-34a to treat multiple myeloma (MM) were developed. Wild type or completely 2′-O-methylated (OMet) MiR-34a was used in this study. Moreover, SNALPs were conjugated with transferrin (Tf) in order to target MM cells overexpressing transferri...
Autores principales: | Scognamiglio, Immacolata, Di Martino, Maria Teresa, Campani, Virginia, Virgilio, Antonella, Galeone, Aldo, Gullà, Annamaria, Gallo Cantafio, Maria Eugenia, Misso, Gabriella, Tagliaferri, Pierosandro, Tassone, Pierfrancesco, Caraglia, Michele, De Rosa, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943297/ https://www.ncbi.nlm.nih.gov/pubmed/24683542 http://dx.doi.org/10.1155/2014/217365 |
Ejemplares similares
-
In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
por: Di Martino, Maria Teresa, et al.
Publicado: (2014) -
Mir-34: A New Weapon Against Cancer?
por: Misso, Gabriella, et al.
Publicado: (2014) -
Myeloid-Derived Suppressor Cells in Multiple Myeloma: Pre-Clinical Research and Translational Opportunities
por: Botta, Cirino, et al.
Publicado: (2014) -
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment
por: Zarone, Mayra Rachele, et al.
Publicado: (2017) -
In Vitro and In Vivo Activity of a Novel Locked Nucleic Acid (LNA)-Inhibitor-miR-221 against Multiple Myeloma Cells
por: Di Martino, Maria Teresa, et al.
Publicado: (2014)